These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity. Carniato F, Tei L, Arrais A, Marchese L, Botta M. Chemistry; 2013 Jan 21; 19(4):1421-8. PubMed ID: 23233428 [Abstract] [Full Text] [Related]
3. Gadolinium(III)-Chelated Silica Nanospheres Integrating Chemotherapy and Photothermal Therapy for Cancer Treatment and Magnetic Resonance Imaging. Cao M, Wang P, Kou Y, Wang J, Liu J, Li Y, Li J, Wang L, Chen C. ACS Appl Mater Interfaces; 2015 Nov 18; 7(45):25014-23. PubMed ID: 26418578 [Abstract] [Full Text] [Related]
4. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles. Xu K, Liu H, Zhang J, Tong H, Zhao Z, Zhang W. Int J Nanomedicine; 2019 Nov 18; 14():7879-7889. PubMed ID: 31576129 [Abstract] [Full Text] [Related]
5. Direct immobilization of manganese chelates on silica nanospheres for MRI applications. Pálmai M, Pethő A, Nagy LN, Klébert S, May Z, Mihály J, Wacha A, Jemnitz K, Veres Z, Horváth I, Szigeti K, Máthé D, Varga Z. J Colloid Interface Sci; 2017 Jul 15; 498():298-305. PubMed ID: 28343127 [Abstract] [Full Text] [Related]
6. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent. Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG, Li C. Bioconjug Chem; 2004 Jul 15; 15(6):1408-15. PubMed ID: 15546209 [Abstract] [Full Text] [Related]
8. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery. Li C, Yang D, Ma P, Chen Y, Wu Y, Hou Z, Dai Y, Zhao J, Sui C, Lin J. Small; 2013 Dec 20; 9(24):4150-9. PubMed ID: 23843254 [Abstract] [Full Text] [Related]
9. Mesoporous silica nanospheres as highly efficient MRI contrast agents. Taylor KM, Kim JS, Rieter WJ, An H, Lin W, Lin W. J Am Chem Soc; 2008 Feb 20; 130(7):2154-5. PubMed ID: 18217764 [No Abstract] [Full Text] [Related]
11. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent. Unger EC, Shen D, Wu G, Stewart L, Matsunaga TO, Trouard TP. MAGMA; 1999 Aug 20; 8(3):154-62. PubMed ID: 10504042 [Abstract] [Full Text] [Related]
12. Stability evaluation of Gd chelates for macromolecular MRI contrast agents. Yokoyama M, Shiraishi K. MAGMA; 2020 Aug 20; 33(4):527-536. PubMed ID: 31823277 [Abstract] [Full Text] [Related]
13. T1-T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents. Li J, You J, Wu C, Dai Y, Shi M, Dong L, Xu K. Int J Nanomedicine; 2018 Aug 20; 13():4607-4625. PubMed ID: 30127609 [Abstract] [Full Text] [Related]
14. Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging. Harrison VS, Carney CE, MacRenaris KW, Waters EA, Meade TJ. J Am Chem Soc; 2015 Jul 22; 137(28):9108-16. PubMed ID: 26083313 [Abstract] [Full Text] [Related]
15. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Puerta DT, Botta M, Jocher CJ, Werner EJ, Avedano S, Raymond KN, Cohen SM. J Am Chem Soc; 2006 Feb 22; 128(7):2222-3. PubMed ID: 16478170 [Abstract] [Full Text] [Related]
16. A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose. Cheng CA, Chen W, Zhang L, Wu HH, Zink JI. J Am Chem Soc; 2019 Nov 06; 141(44):17670-17684. PubMed ID: 31604010 [Abstract] [Full Text] [Related]
18. Conjugation of glucosamine with Gd3+-based nanoporous silica using a heterobifunctional ANB-NOS crosslinker for imaging of cancer cells. Mehravi B, Ahmadi M, Amanlou M, Mostaar A, Ardestani MS, Ghalandarlaki N. Int J Nanomedicine; 2013 Nov 06; 8():3383-94. PubMed ID: 24101868 [Abstract] [Full Text] [Related]
19. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents. Zong Y, Wang X, Jeong EK, Parker DL, Lu ZR. Magn Reson Imaging; 2009 May 06; 27(4):503-11. PubMed ID: 18814987 [Abstract] [Full Text] [Related]
20. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer. Khantasup K, Saiviroonporn P, Jarussophon S, Chantima W, Dharakul T. MAGMA; 2018 Oct 06; 31(5):633-644. PubMed ID: 29737435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]